view article

Figure 4
Binding of BMN 673 at the extended binding pocket. (a) Structural variability of the D-loop illustrated on superimposed crystallographic structures of PARP3 (PDB entry 3fhb ; Lehtiö et al., 2009BB20), tankyrase 1 (2rf5 ; Lehtiö et al., 2008BB19) and tankyrase 2 (3kr7 ; Karlberg, Markova et al., 2010BB15), PARP1 and PARP2. (b) Unlike the other PARP1 inhibitors shown in cyan [PDB entries 1uk1 (Hattori et al., 2004BB11), 1uk0 (Kinoshita et al., 2004BB16), 3gjw (Miyashiro et al., 2009BB24), 4hhz (Ye et al., 2013BB44) and 4l6s (Gangloff et al., 2013BB9)] and orange [PDB entries 1wok (Iwashita et al., 2005BB12), 2rd6 , 2rcw and 3gn7 (C. R. Park, unpublished work), 3l3m (Penning et al., 2010BB34), 3l3l (Gandhi et al., 2010BB8) and 4gv7 (Lindgren et al., 2013BB22)] which are directed towards sub-sites 1 and 2, a disubstituted BMN 673 molecule occupies a unique space within the extended NAD+-binding pocket.

Journal logoSTRUCTURAL BIOLOGY
COMMUNICATIONS
ISSN: 2053-230X
Follow Acta Cryst. F
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds